MCAZ
Menu
Staff Email
FAQs
Whatsapp
Facebook
Twitter
Instagram
Linkedin
Youtube
Menu
Home
About Us
Who We Are
MCAZ Board Members
Careers @ MCAZ
Privacy Policy
Tenders
Corporate Governance
Board Charter
Client Service Charter
Our Strategic Plan
Regulatory Functions
Evaluation and Registration
Overview
Find A Registered Medicine
How to Register
Alternative Submission Pathways
Registered & Approved Medicines
Human Medicines Guidelines
Key timelines
Important Information
Summary of Product Characteristics
Licensing and Enforcement
Overview
Licensing
Inspections
Import & Export
Product Defects & Recalls
Medicinal Cannabis
Enquiries
Pharmacovigilance and Clinical Trials
Current Projects
Pharmacovigilance Centre
Clinical Trials
WHO Pharmacovigilance Toolkit
Clinical Trial Public Registry Platform
Laboratory Services
Medical Devices Laboratory
Microbiology Laboratory
Chemistry Laboratory
Legal and Coperate Affairs
Overview
Procurement Section
Tenders
Request For Quotations
Online Services
Online Registers
Import/Export for Registered Medicines
Section 75 Authorisation
Online Persons and Premises Renewals
ADR E-Reporting
Consumer Reporting
Healthcare Professional Reporting
e-Clinical Trials
Publications
Annual Reports
Press Release
Vaccine Safety
Downloads
RCore Trainings
Contact Us
APPLICATION FOR THE ISSUE OF A SALES REPRESENTATIVES PERMIT
APPLICATION FOR THE ISSUE OF A SALES REPRESENTATIVES PERMIT
830
Downloads
Download Now!
Size:
8KB
About the Author
Post navigation
Circular 16 of 2021 – Use of Ivermectin human oral formulations for prevention and or treatment of COVID 19
MCAZ-Clinical Trials RCORE Brochure September 2019
You may also like these
No Related Post
